Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    8639764 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
Condition: Myelodysplastic Syndrome
Intervention: Drug: Darbepoetin alfa

Study has passed its completion date and status has not been verified in more than two years.